BofA Securities upgraded DuPont from Underperform to Neutral and set a new price target of $75.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/3/2025 | $75.00 → $85.00 | Buy | Citigroup |
| 4/15/2025 | $75.00 | Underperform → Neutral | BofA Securities |
| 4/14/2025 | $81.00 | Sector Weight → Overweight | KeyBanc Capital Markets |
| 2/13/2025 | $85.00 → $89.00 | Underweight → Equal Weight | Barclays |
| 1/17/2025 | $91.00 | Peer Perform → Outperform | Wolfe Research |
| 10/7/2024 | $88.00 → $84.00 | Equal Weight → Underweight | Barclays |
| 5/28/2024 | $85.00 → $95.00 | Neutral → Buy | Citigroup |
| 5/24/2024 | $80.00 → $103.00 | Equal Weight → Overweight | Wells Fargo |
New FilmTec™ MXP RO-8038-FF reverse osmosis element provides enhanced productivity and operational performance in a mesh wrapped configuration, enabling high-quality dairy products WILMINGTON, Del., Feb. 4, 2026 /PRNewswire/ -- DuPont (NYSE:DD) today announced the launch of the FilmTec™ MXP RO-8038-FF element—an advanced mesh wrapped reverse osmosis solution engineered for dairy processors who rely on mesh wrapped systems and now seek greater active area and higher productivity. As dairy producers seek to maximize throughput while maintaining trusted operational practices, Fil
Improved-rheology medical-grade LSR offers process flexibility for fabricating medical devices, including devices intended for implantation in humans for less than 30 days, as well as for non-implant applications WILMINGTON, Del., Feb. 3, 2026 /PRNewswire/ -- DuPont (NYSE:DD) today announced the launch of Liveo™ C6-8XX Liquid Silicone Rubber (LSR), a new USP Class VI (C6) series of medical-grade, two-part silicone elastomers engineered to meet the stringent requirements of medical device applications. The Liveo™ C6-8XX LSR series delivers precision, reliability and processing
Upgraded weak base anion resin delivers enhanced operating capacity, longer run lengths, and greater fouling resistance to support cost-efficient production of lactic and citric acids WILMINGTON, Del., Jan. 28, 2026 /PRNewswire/ -- DuPont (NYSE:DD) today announced the launch of DuPont™ AmberLite™ FPA57 resin, an innovative weak base anion resin designed to support the growing needs of organic acid manufacturers. Organic acids play a critical role across the food and beverage, personal care, biodegradable plastics, and pharmaceutical industries. They are essential in processes
3 - DuPont de Nemours, Inc. (0001666700) (Issuer)
4 - DuPont de Nemours, Inc. (0001666700) (Issuer)
4 - DuPont de Nemours, Inc. (0001666700) (Issuer)
Citigroup reiterated coverage of DuPont with a rating of Buy and set a new price target of $85.00 from $75.00 previously
BofA Securities upgraded DuPont from Underperform to Neutral and set a new price target of $75.00
KeyBanc Capital Markets upgraded DuPont from Sector Weight to Overweight and set a new price target of $81.00
8-K - DuPont de Nemours, Inc. (0001666700) (Filer)
8-K - DuPont de Nemours, Inc. (0001666700) (Filer)
8-K - DuPont de Nemours, Inc. (0001666700) (Filer)
SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)
SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)
SC 13G - DuPont de Nemours, Inc. (0001666700) (Subject)
WILMINGTON, Del., Jan. 20, 2026 /PRNewswire/ -- DuPont (NYSE:DD) today announced the appointment of D.G. Macpherson to its Board of Directors, effective immediately. "We are very pleased to welcome D.G. to the DuPont board," said Lori Koch, DuPont Chief Executive Officer. "D.G. brings deep expertise in operational excellence, supply chain optimization, and business transformation, which will be invaluable as we execute our growth strategy and deliver long-term value to shareholders, customers, and employees. His passion for innovation and commitment to continuous improvement m
NEW YORK, Oct. 27, 2025 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P SmallCap 600: Solstice Advance Materials Inc. (NASD: SOLS) will replace CarMax Inc. (NYSE:KMX) in the S&P 500, and CarMax will replace USANA Health Sciences Inc. (NYSE:USNA) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, October 31. S&P 500 and 100 constituent Honeywell International Inc. (NASD: HON) is spinning off Solstice Advance Materials in a transaction expected to be completed on October 30. Post spin-off, Honeywell International will remain in the S&P 500 and 100. CarMax and USANA Health Sciences no longer represent the large cap and small c
WILMINGTON, Del., Feb. 21, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced the appointment of Kurt McMaken to its Board of Directors, effective immediately. Mr. McMaken will serve on the Audit committee and Nomination and Governance committee. "We are pleased to welcome Kurt to DuPont's Board of Directors," said DuPont Executive Chairman Ed Breen. "Kurt's global business expertise in the manufacturing sector and extensive background in finance and strategic planning make him well suited to help guide DuPont's growth and value creation strategies. We look forward to his c
WILMINGTON, Del., Jan. 21, 2026 /PRNewswire/ -- DuPont (NYSE:DD) will release its fourth quarter and full year 2025 financial results at 6:00 a.m. ET on Tuesday, February 10, 2026. In addition, the company will host a conference call at 8:00 a.m. ET that day. The event will be webcast live and can be accessed on DuPont's Investors Relations webpage. A replay, along with the earnings release and supporting materials, will also be posted to the website. The dial-in number for the conference call is 888-440-4172 toll-free within the U.S. or +1-646-960-0673. The conference ID is 5
Exceeds 3Q 2025 Guidance for Total DuPont Raises FY 2025 Earnings Guidance for New DuPont Announces $2 Billion Share Repurchase Authorization, $500 Million Accelerated Share Repurchase and New DuPont Quarterly Dividend Third Quarter 2025 Highlights Net Sales of $3.1 billion increased 7%; organic sales increased 6% versus year-ago periodGAAP Income from continuing operations of $308 million; operating EBITDA of $840 millionGAAP EPS from continuing operations of $0.70; adjusted EPS of $1.09Cash provided by operating activities from continuing operations of $591 million; transaction-adjusted free cash flow of $576 millionRaises FY 2025 operating EBITDA guidance for new DuPont to $1.6 billionCap
WILMINGTON, Del., Oct. 20, 2025 /PRNewswire/ -- DuPont (NYSE:DD) will release its third quarter financial results at 6:00 a.m. ET on Thursday, November 6, 2025. In addition, the company will host a conference call at 8:00 a.m. ET that day. The event will be webcast live and can be accessed on DuPont's Investors Relations webpage. A replay, along with the earnings release and supporting materials, will also be posted to the website. The dial-in number for the conference call is 888-440-4172 toll-free within the U.S. or +1-646-960-0673. The conference ID is 5994046. DuPont will